Across the EU, Norway and Türkiye, the national focal points (NFPs) of the Reitox network curate and contextualise national drug information and contribute to situational analysis and early signal detection in their country to feed into the European picture. To support the quality and consistency of this work, the EUDA assesses each NFP’s contribution to the agency’s tasks, as well as its national coordination, data management and collaboration processes.
Foreseen in the EUDA founding regulation (Article 35), the assessments are based on information provided by the NFPs and typically include onsite visits and in-depth discussions with national teams. They are designed to strengthen the quality of the work carried out for the agency under the EUDA Regulation and the Reitox Alliance framework.
This month marked the completion of the first full assessment cycle, launched in 2020, with the final visit taking place in Madrid on 20-21 May. All assessed NFPs successfully met the required standards.
The EUDA would like to thank and congratulate the NFP teams for their strong engagement, professionalism and commitment throughout the process.
